1. Home
  2. IMMR vs CMPX Comparison

IMMR vs CMPX Comparison

Compare IMMR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMR
  • CMPX
  • Stock Information
  • Founded
  • IMMR 1993
  • CMPX 2014
  • Country
  • IMMR United States
  • CMPX United States
  • Employees
  • IMMR N/A
  • CMPX N/A
  • Industry
  • IMMR Computer peripheral equipment
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMMR Technology
  • CMPX Health Care
  • Exchange
  • IMMR Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • IMMR 247.2M
  • CMPX 291.8M
  • IPO Year
  • IMMR 1999
  • CMPX N/A
  • Fundamental
  • Price
  • IMMR $7.86
  • CMPX $2.99
  • Analyst Decision
  • IMMR Strong Buy
  • CMPX Strong Buy
  • Analyst Count
  • IMMR 2
  • CMPX 9
  • Target Price
  • IMMR $12.25
  • CMPX $12.67
  • AVG Volume (30 Days)
  • IMMR 469.3K
  • CMPX 872.7K
  • Earning Date
  • IMMR 08-19-2025
  • CMPX 08-11-2025
  • Dividend Yield
  • IMMR 2.30%
  • CMPX N/A
  • EPS Growth
  • IMMR 57.07
  • CMPX N/A
  • EPS
  • IMMR 2.04
  • CMPX N/A
  • Revenue
  • IMMR $163,133,000.00
  • CMPX $850,000.00
  • Revenue This Year
  • IMMR $988.71
  • CMPX N/A
  • Revenue Next Year
  • IMMR $109.72
  • CMPX N/A
  • P/E Ratio
  • IMMR $3.84
  • CMPX N/A
  • Revenue Growth
  • IMMR 338.21
  • CMPX N/A
  • 52 Week Low
  • IMMR $6.47
  • CMPX $0.87
  • 52 Week High
  • IMMR $13.94
  • CMPX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • IMMR 53.50
  • CMPX 70.40
  • Support Level
  • IMMR $7.64
  • CMPX $2.64
  • Resistance Level
  • IMMR $8.00
  • CMPX $3.27
  • Average True Range (ATR)
  • IMMR 0.19
  • CMPX 0.18
  • MACD
  • IMMR -0.02
  • CMPX 0.04
  • Stochastic Oscillator
  • IMMR 46.23
  • CMPX 81.82

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: